Get started
Author

Melissa Walker

Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
2010 · Steven K. Libutti, Giulio F. Paciotti, et al. · Clinical Cancer Research · 713
Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial
2014 · Udo Rudloff, Russell C. Langan, et al. · Journal of Surgical Oncology · 231
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
2020 · Changqing Xie, Austin G. Duffy, et al. · Clinical Cancer Research · 101
Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer
2018 · Changqing Xie, Austin G. Duffy, et al. · Hepatology · 101
Screening, Diagnosis, and Management of Intrauterine Growth Restriction
2012 · Andrea Lausman, Fergus P. McCarthy, et al. · Journal of Obstetrics and Gynaecology Canada · 89
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750—an antisense oligonucleotide against eIF4E—in combination with irinotecan in solid tumors and irinotecan‐refractory colorectal cancer
2016 · A.G. Duffy, O.V. Makarova‐Rusher, et al. · International Journal of Cancer · 77
PDF
The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone
2009 · Sid P Kerkar, Clinton D Kemp, et al. · Trials · 68
PDF
Folic Acid Supplementation in Early Second Trimester and the Risk of Preeclampsia
2009 · S. W. Wen, X. K. Chen, et al. · Obstetric Anesthesia Digest · 49
A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer
2019 · Charalampos S. Floudas, Gagandeep Brar, et al. · Clinical Colorectal Cancer · 45
PDF
Combined immune checkpoint inhibition (ICI) with tremelimumab and durvalumab in patients with advanced hepatocellular carcinoma (HCC) or biliary tract carcinomas (BTC).
2019 · Charalampos S. Floudas, Changqing Xie, et al. · Journal of Clinical Oncology · 43
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib
2015 · AG Duffy, SV Ulahannan, et al. · United European Gastroenterology Journal · 42
PDF
Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinoma
2011 · Simon R. Best, Patrick K. Ha, et al. · Head & Neck · 40
Results of a completed phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine
2009 · S. K. Libutti, G. F. Paciotti, et al. · Journal of Clinical Oncology · 35
Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation
2021 · Meredith J. McAdams, Mustafa Hyder, et al. · Blood · 32
Ultrasound diagnosis of severe thrombotic placental damage in the second trimester: an observational study
2004 · F. Alkazaleh, S. Viero, et al. · Ultrasound in Obstetrics and Gynecology · 31
A pilot study of AMP-224, a PD-L2 Fc fusion protein, in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic colorectal cancer.
2016 · Austin G. Duffy, Oxana V. Makarova-Rusher, et al. · Journal of Clinical Oncology · 24
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
2011 · Jeremy L Davis, Prakash Pandalai, et al. · Trials · 20
PDF
Tremelimumab, a monoclonal antibody against CTLA-4, in combination with subtotal ablation (trans-catheter arterial chemoembolization [TACE], radiofrequency ablation [RFA] or cryoablation) in patients with hepatocellular carcinoma (HCC) and biliary tract carcinoma (BTC).
2016 · Austin G. Duffy, Oxana V. Makarova-Rusher, et al. · Journal of Clinical Oncology · 19
A pilot study of tremelimumab – a monoclonal antibody against CTLA-4 – in combination with either trans catheter arterial chemoembolization (TACE) or radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC).
2015 · Austin G. Duffy, Oxana V. Makarova-Rusher, et al. · Journal of Clinical Oncology · 18
A pilot study of tremelimumab, a monoclonal antibody against CTLA-4, in combination with either transcatheter arterial chemoembolization (TACE) or radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC).
2014 · Austin G. Duffy, Susanna Varkey Ulahannan, et al. · Journal of Clinical Oncology · 18
Maternal plasma homocysteine levels in women with preterm premature rupture of membranes
2001 · S.E. Ferguson, G.N. Smith, et al. · Medical Hypotheses · 18
A phase I/II study of Pexa-Vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer.
2020 · M. Cecilia Monge B., Changqing Xie, et al. · Journal of Clinical Oncology · 17
Pathologic basis of improving the screening utility of 2-dimensional placental morphology ultrasound
2012 · D. Costantini, M. Walker, et al. · Placenta · 14
A phase I/II study of pexa-vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer: Safety report.
2019 · Maria Pia Morelli, Changqing Xie, et al. · Journal of Clinical Oncology · 11
Tremelimumab: A monoclonal antibody against CTLA-4—In combination with subtotal ablation (trans catheter arterial chemoembolization (TACE), radiofrequency ablation (RFA) or cryoablation) in patients with hepatocellular carcinoma (HCC) and biliary tract carcinoma (BTC).
2016 · Austin G. Duffy, Oxana V. Makarova-Rusher, et al. · Journal of Clinical Oncology · 10
Works count: 46
Citation count: 1,927
H-index: 18
I10-index: 25
Year
Topic
Type